Healthy Clinical Trial
— SRPTOfficial title:
Local Changes of Skin Characteristics During and After an Application of a Topical Product With a Warming or Cooling Effect - a Randomized, Controlled Clinical Trial
| NCT number | NCT03016221 |
| Other study ID # | 2016-01541 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | May 1, 2017 |
| Est. completion date | December 6, 2019 |
| Verified date | June 2019 |
| Source | University of Applied Sciences and Arts of Southern Switzerland |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The use of topical over-the-counter (OTC) products with a warming or cooling effect is widespread in the fields of sport, physiotherapy and in private households. Advertisements for such products promise pain relief when suffering from musculoskeletal disorders such as muscle tension, rheumatism or acute injuries, e.g. sprains. In literature, there are only little information about the efficacy and the physiological mechanisms of topical warming or cooling products. Therefore, the aim of this study is to investigate the local skin characteristics during and after an application of a topical product with a warming or cooling effect.
| Status | Completed |
| Enrollment | 90 |
| Est. completion date | December 6, 2019 |
| Est. primary completion date | December 6, 2019 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | 18 Years to 40 Years |
| Eligibility |
Inclusion Criteria: - no existing musculoskeletal disorders in the region of interest - no surgery in the region of interest in the last year - healthy skin conditions in the region of interest Exclusion Criteria: - fear of treatment - regular intake of drugs, excluding contraceptives - metal implants in the region between C7 and sacrum, including hip joints - lack of epicritic and protopathic skin sensitivity - renal insufficiency - bronchial asthma - pregnancy/lactation - type 1 or 2 diabetes mellitus - polyneuropathy |
| Country | Name | City | State |
|---|---|---|---|
| Switzerland | SUPSI | Landquart | GR |
| Lead Sponsor | Collaborator |
|---|---|
| University of Applied Sciences and Arts of Southern Switzerland |
Switzerland,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | local skin perfusion | local skin perfusion will be measured with a laser speckle instrument | during one hour post application | |
| Primary | local skin redness | local skin redness (erythema) will be measured with a chromameter | during one hour post application | |
| Primary | skin surface temperature | skin surface temperature will be measured with thermochrons, infrared thermometer and thermal imaging camera | during one hour post application | |
| Primary | local muscle tissue oxygenation | local muscle tissue oxygenation will be measured with near infrared spectroscopy | during one hour post application | |
| Primary | subjective temperature sensation | subjective temperature sensation will be evaluated with a thermal comfort questionnaire | during one hour post application | |
| Secondary | skin perfusion directly next to the application area | skin perfusion will be measured with a laser speckle instrument | during one hour post application | |
| Secondary | skin redness directly next to the application area | skin redness (erythema) will be measured with a chromameter | during one hour post application | |
| Secondary | skin temperature directly next to the application area | skin surface temperature will be measured with thermochrons, infrared thermometer and thermal imaging camera | during one hour post application | |
| Secondary | muscle tissue oxygenation directly next to the application area | muscle tissue oxygenation will be measured with near infrared spectroscopy | during one hour post application | |
| Secondary | subjective temperature sensation directly next to the application area | subjective temperature sensation will be evaluated with a thermal comfort questionnaire | during one hour post application |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06052553 -
A Study of TopSpin360 Training Device
|
N/A | |
| Completed |
NCT05511077 -
Biomarkers of Oat Product Intake: The BiOAT Marker Study
|
N/A | |
| Recruiting |
NCT04632485 -
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
|
||
| Completed |
NCT05931237 -
Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults
|
N/A | |
| Completed |
NCT04527718 -
Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
|
Phase 1 | |
| Terminated |
NCT04556032 -
Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women
|
N/A | |
| Completed |
NCT04107441 -
AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT04065295 -
A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225
|
Phase 1 | |
| Completed |
NCT04998695 -
Health Effects of Consuming Olive Pomace Oil
|
N/A | |
| Completed |
NCT01442831 -
Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects
|
Phase 1 | |
| Terminated |
NCT05934942 -
A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood
|
Phase 1 | |
| Recruiting |
NCT05525845 -
Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI
|
N/A | |
| Completed |
NCT05515328 -
A Study in Healthy Men to Test How BI 685509 is Processed in the Body
|
Phase 1 | |
| Completed |
NCT04967157 -
Cognitive Effects of Citicoline on Attention in Healthy Men and Women
|
N/A | |
| Completed |
NCT05030857 -
Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects
|
Phase 1 | |
| Recruiting |
NCT04714294 -
Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04494269 -
A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls
|
Phase 1 | |
| Completed |
NCT04539756 -
Writing Activities and Emotions
|
N/A | |
| Recruiting |
NCT04098510 -
Concentration of MitoQ in Human Skeletal Muscle
|
N/A | |
| Completed |
NCT03308110 -
Bioavailability and Food Effect Study of Two Formulations of PF-06650833
|
Phase 1 |